Omniox Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Debt - PPP
  • Investors
  • 11

Omniox General Information

Description

Developer of a bio-therapeutics platform designed to develop novel biologics targeting hypoxia in ischemia and oncology. The company's platform develops new medicines for hypoxic diseases such as cancer, cardiovascular diseases, trauma and other conditions, enabling healthcare professionals to oxygenate pathologically hypoxic tissue and restore normal tissue function with the potential for improved outcomes and patient cures.

Contact Information

Website
www.omniox.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Drug Delivery
Primary Office
  • 75 Shoreway Road
  • Suite B
  • San Carlos, CA 94070
  • United States
+1 (650) 000-0000

Omniox Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Omniox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Debt - PPP 28-Apr-2020 000.00 Completed Generating Revenue
9. Later Stage VC (Series D) 23-Mar-2018 0000 000.00 00000 Completed Generating Revenue
8. Accelerator/Incubator 07-Feb-2017 000.00 Completed Generating Revenue
7. Grant 09-Oct-2014 00.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series C) 18-Jun-2014 00.00 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series B) 24-Jun-2013 00.000 00.000 000.00 Completed Generating Revenue
4. Later Stage VC (Series A) 06-Jul-2012 000 000 000.00 Completed Generating Revenue
3. Grant 01-Dec-2009 00000 Completed Startup
2. Grant 01-Jan-2008 $9.6M Completed Startup
1. Grant 01-Jan-2007 $250K Completed Startup
To view Omniox’s complete valuation and funding history, request access »

Omniox Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 000,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.00
Series B 4,346,382 $0.000100 8% $0.71 $0.71 1x $0.71 3.9%
Series A 3,150,959 $0.000100 8% $0.57 $0.57 1x $0.57 2.83%
To view Omniox’s complete cap table history, request access »

Omniox Executive Team (5)

Name Title Board Seat Contact Info
Jonathan Winger Ph.D Co-Founder & Chief Executive Officer
Julia Simmons Senior Director & Controller
Michael Marletta Ph.D Co-Founder
Stephen Cary Ph.D Co-Founder
You’re viewing 4 of 5 executive team members. Get the full list »

Omniox Board Members (2)

Name Representing Role Since
Ajit Shah Ph.D Self Board Member 000 0000
Jeffrey Samberg Acadia Woods Partners Board Member 000 0000
To view Omniox’s complete board members history, request access »

Omniox Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Omniox Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Acadia Woods Partners Venture Capital Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
EcoR1 Capital Hedge Fund Minority 000 0000 000000 0
Emerson Corporation Minority 000 0000 000000 0
Plug and Play Tech Center Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »